Pheochromocytoma and Paraganglioma: Scientific Articles

Featured Articles

The following featured articles include those from NICHD researchers or NICHD-supported researchers:

  • Giubellino, A., Bullova, P., Nolting, S., Turkova, H., Powers, J. F., Liu, Q. et al. (2013). Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: In vitro and in vivo studies in female athymic nude mice. Endocrinology, 154(2),646–655. PMID: 23307788
  • Giubellino, A., Sourbier, C., Lee, M. J., Scroggins, B., Bullova, P., Landau, M. et al. (2013). Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma. PLoS One, 8(2),e56083. PMID: 23457505
  • Matro, J., Giubellino, A., & Pacak, K. (2013). Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: Focus on SDHB tumors. Hormone and Metabolic Research, 45(2),147–153. PMID: 23322515
  • Pacak, K., Jochmanova, I., Prodanov, T., Yang, C., Merino, M. J., Fojo, T., et al. (2013). New syndrome of paraganglioma and somatostatinoma associated with polycythemia. Journal of Clinical Oncology, 31(13),1690–1698. PMID: 23509317
  • Taïeb, D., Yang, C., Delenne, B., Zhuang, Z., Barlier, A., Sebag, F., et al. (2013). First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome. Journal of Clinical Endocrinology and Metabolism, 98(5),E908–E913. PMID: 23539726
  • Vicha, A., Musil, Z., & Pacak, K. (2013). Genetics of pheochromocytoma and paraganglioma syndromes: New advances and future treatment options. Current Opinion in Endocrinology, Diabetes, and Obesity, 20(3),186–191. PMID: 23480210
  • Eisenhofer, G., Lenders, J. W., Siegert, G., Bornstein, S. R., Friberg, P., Milosevic, D., et al. (2012). Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. European Journal of Cancer, 48(11), 1739–1749. PMID: 22036874
  • Fonte, J. S., Robles, J. F., Chen, C. C., Reynolds, J., Whatley, M., Ling, A., et al. (2012). False-negative I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocrine-Related Cancer, 19(1), 83–93. PMID: 22167067
  • Giubellino, A., Woldemichael, G. M., Sourbier, C., Lizak, M. J., Powers, J. F., Tischler, A. S., et al. (2012). Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging. Cancer Letters, 316(1),46–52. PMID: 22154086
  • Shah, U., Giubellino, A., & Pacak, K. (2012). Pheochromocytoma: Implications in tumorigenesis and the actual management. Minerva Endocrinologica, 37(2), 141–156. PMID: 22691888
  • Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., et al. (2012). Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. New England Journal of Medicine, 367(10),922–930. PMID: 22931260
  • Eisenhofer, G., Lenders, J. W., Timmers, H., Mannelli, M., Grebe, S. K., Hofbauer, L. C., et al. (2011). Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clinical Chemistry, 57, 411–420. PMID: 21262951
  • King, K. S., Prodanov, T., Kantorovich, V., Fojo, T., Hewitt, J. K., Zacharin, M., et al. (2011). Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: Significant link to SDHB mutations. Journal of Clinical Oncology, 29, 4137–4142. PMID: 21969497

PubMed Search Results

Use the links below to search the PubMed database of more than 20 million citations for scientific articles.

top of pageBACK TO TOP